Two Sigma Investments, LP Pulse Biosciences, Inc. Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.48 - $4.28 $88,261 - $255,242	-59,636 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.21 - $14.79 $251,067 - $882,016	59,636 New	59,636 $290,000
Q4 2021 Feb 14, 2022	SELL	$14.78 - $24.4 $311,473 - $514,205	-21,074 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.25 - $26.63 $863,466 - $1.33 Million	-50,056 Reduced 70.37%	21,074 $455,000
Q2 2021 Aug 16, 2021	BUY	$16.31 - $23.64 $113,011 - $163,801	6,929 Added 10.79%	71,130 $1.17 Million
Q1 2021 May 17, 2021	BUY	$22.43 - $44.27 $1.44 Million - $2.84 Million	64,201 New	64,201 $1.52 Million

5.39M

139K

84.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $777M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.